Coronavirus: Hydroxychloroquine – A Cure to be Suppressed

Part 3

“In my opinion, tens of thousands are dying unnecessarily. Our current approach of waiting for these high-risk patients to become ill and then hospitalizing them is failing. The answer is early diagnosis of the high-risk individuals, and then treating them as outpatients with the HCQ cocktail to prevent hospitalization.” – George C Fareed, MD [1]


Click to download the audio (MP3 format)

The COVID virus without a doubt, has dominated discussions in the broader community. The measures aiming to control the bug have become extreme. Many employees are wondering whether or not they’ll return to work. Many people in centres around the world wonder if even we will return to a pre-pandemic era.

Increasingly, World Health Organizations (WHO) tell us that the fastest solution will be a vaccine admitted to all or most people on the planet.

Is vaccination the only answer to the plague of the 21st century?

According to many, many medical doctors, the answer is “no.”

A medication called hydroxychloroquine in combination with azithromycin or doxycycline and zinc, when applied to patients within the early stages of the illness, have made a resounding improvement on their prospects to recover completely. An effective treatment, with no evidence of significant side effects. [2]

One small problem. Hydroxychloroquine has faced a barrage of negative press among major press organizations. It was continually accused of negative consequences and finally got crossed off of the solutions hit list after a famous study on it was published in the prestigious medical journal: The Lancet.

When a group of “America’s Frontline Doctors” was promoting the medication on Facebook and YouTube, the event, after having attracted engagement by the millions was pulled down from both social platforms on the grounds that the video shared “false” or “harmful” information about COVID or otherwise “violating YouTube community guidelines.” [3]

And of course, the thought of President Trump promoting Hydroxychloroquine as a treatment stirred up enough opposition from his political opponents to give that drug a wide berth.

Is there a deeper layer of meaning behind this humble pill’s personality assassination? We devote the show to finding out.

Our first interview is with Jane Orient, MD. On behalf of the Association of American Physicians and Surgeons, she talks about the unfairness of blocking dissemination of the drug by doctors and about the legal actions taken against the Food and Drug Administration by the organization.

Then we hear from Meryl Nass, MD about the plan to deconstruct and discourage use of Hydroxychloroquine by the WHO, the medical journals and even the media.

Finally, we hear from three researchers: Roland Derwand, MD, Martin Scholz, PhD, and Vladimir Zelenko, MD. They discuss the study pioneering early intervention with Hydroxychloroquine “cocktails” and measuring their success as a COVID 19 treatment.

Jane Orient, MD is a general and internal physician based in Tucson, Arizona. She is the Executive Director of the Association of American Physicians and Surgeons.

Meryl Nass, MD is a General Internal Medicine Physician with 40 years of experience. She is an epidemic and anthrax expert and composes a series of blogs for the site Anthrax Vaccine as well as Global Research. She’s based in Ellsworth, Maine.

Roland Derwand, MD is a German doctor and a life science industry expert. He currently heads the medical affairs department of a U.S. biotech company in Germany.

Martin Scholz, PhD is an independent consultant and adjunct professor for experimental medicine at Heinrich Heine University, Düsseldorf, Germany.

Vladimir Zelenko, MD is a family physician based in New York City. He is medical director at the Monsey Family Medical Center.

(Global Research News Hour Episode 290)


Click to download the audio (MP3 format)

The Global Research News Hour airs every Friday at 1pm CT on CKUW 95.9FM in Winnipeg. The programme is also podcast at .


  1. George C Fareed, MD, Open letter to Congressman Juan Vargas, ‘Medical Studies Support MDs Prescribing Hydroxychloroquine for Early Stage COVID-19 and for Prophylaxis’, P. 241
  2. ibid

Comment on Global Research Articles on our Facebook page

Become a Member of Global Research

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected] contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]